GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » YoY EPS Growth

Scancell Holdings (LSE:SCLP) YoY EPS Growth : 50.00% (As of Oct. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Scancell Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Scancell Holdings's YoY EPS Growth for the quarter that ended in Oct. 2023 was 50.00%.

Scancell Holdings's Earnings per Share (Diluted) for the six months ended in Oct. 2023 was £-0.00.


Scancell Holdings YoY EPS Growth Historical Data

The historical data trend for Scancell Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings YoY EPS Growth Chart

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.69 14.29 -91.67 73.91 -150.00

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 157.14 43.75 -250.00 - 50.00

Scancell Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Scancell Holdings's YoY EPS Growth for the fiscal year that ended in Apr. 2023 is calculated as:

YoY EPS Growth (A: Apr. 2023 )
=(Earnings per Share (Diluted) (A: Apr. 2023 )-Earnings per Share (Diluted) (A: Apr. 2022 ))/ | Earnings per Share (Diluted) (A: Apr. 2022 ) |
=(-0.015--0.006)/ | -0.006 |
=-150.00 %

Scancell Holdings's YoY EPS Growth for the quarter that ended in Oct. 2023 is calculated as:

YoY EPS Growth (Q: Oct. 2023 )
=(Earnings per Share (Diluted) (Q: Oct. 2023 )-Earnings per Share (Diluted) (Q: Oct. 2022 )) / | Earnings per Share (Diluted) (Q: Oct. 2022 )) |
=(-0.003--0.006)/ | -0.006 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scancell Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (LSE:SCLP) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (LSE:SCLP) Headlines

No Headlines